Crossmark

A scoping methodological review of simulation studies comparing statistical and machine learning approaches to risk prediction for time-to-event data

Published Online: 2022-06-02

Authors

Smith, Hayley http://orcid.org/0000-0003-3636-9857
Sweeting, Michael

Morris, Tim

Crowther, Michael J.
Funding

Funding for this research was provided by:

Health Data Research UK

Medical Research Council (MC_UU_00004/07)
License Information

Text and Data Mining valid from 2022-06-02

Version of Record valid from 2022-06-02
More Information

Article History

Received: 1 November 2021

Accepted: 1 March 2022

First Online: 2 June 2022

Declarations

:

: Not applicable.

: Not applicable.

: MS is a full-time employee of AstraZeneca. TM provides paid consultancy to Kite Pharma, Inc. and to Alliance Pharmaceutical Limited, and earns personal income from teaching short courses on simulation studies.

Document is current